Dianthus Therapeutics | MGTA - Net Income

Stock Price
78.75
Daily Change
-0.15 -0.19%
Monthly
65.89%
Yearly
279.70%
Q1 Forecast
75.51

Dianthus Therapeutics reported $-36.76M in Net Income for its fiscal quarter ending in September of 2025.





Net Income Change Date
Akebia Therapeutics USD 6.11M 28.92M Mar/2025
Alaunos Therapeutics USD -1.16M 417K Sep/2025
Avita Medical AUD -11.62M 1.7M Dec/2025
Celltrion KRW 331.35B 270.18B Sep/2025
Cspc Pharmaceutical CNY 963.54M 106.35M Sep/2025
Deva Holding AS TRY 583.98M 319.1M Sep/2023
Dianthus Therapeutics USD -36.76M 5.13M Sep/2025
Divis Laboratories Ltd INR 5.83B 1.06B Dec/2025
IQVIA Holdings USD 514M 183M Dec/2025
Kangmei Pharma CNY -3.82M 12.21M Sep/2025
Knight Therapeutics CAD -3.79M 8.83M Sep/2025
Laboratorios Farma EUR 103.69M 37.04M Dec/2023
Malin Corporation EUR -1.1M 2.2M Dec/2023
Medical Developments International AUD -226K 121K Dec/2025
Moderna USD -200M 625M Sep/2025
Neuren Pharmaceuticals AUD 15.4M 7.88M Dec/2025
Organigram Holdings CAD -37.96M 31.67M Sep/2025
Organon & Co USD 160M 15M Sep/2025
Ovoca Bio EUR -5.65M 3.28M Jun/2022
Pharma Mar EUR 59.66M 63.76M Dec/2025
Qiagen NV USD 107.83M 22.21M Dec/2025
Revvity USD 98.36M 51.71M Dec/2025
Sartorius EUR 43.8M 11.3M Sep/2025
Sino Biopharmaceutical CNY 3.39B 2.91B Jun/2025
Tectonic Therapeutic USD -19.04M 940K Sep/2025
Tilray USD -44.93M 44.61M Sep/2025
Viatris USD -340.1M 211.9M Dec/2025
Xeris Pharmaceuticals USD 621K 2.55M Sep/2025
Zz Pientze Pharmaceu CNY 687.04M 244.51M Sep/2025